Detalles de la búsqueda
1.
Associations between detectable circulating tumor DNA and tumor glucose uptake measured by 18F-FDG PET/CT in early-stage non-small cell lung cancer.
BMC Cancer
; 23(1): 646, 2023 Jul 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37434111
2.
Fragmentation assessment of FFPE DNA helps in evaluating NGS library complexity and interpretation of NGS results.
Exp Mol Pathol
; 126: 104771, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35427578
3.
High-dose versus standard-dose twice-daily thoracic radiotherapy for patients with limited stage small-cell lung cancer: an open-label, randomised, phase 2 trial.
Lancet Oncol
; 22(3): 321-331, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33662285
4.
Randomized phase III trial comparing switch-maintenance pemetrexed with observation followed by pemetrexed at progression in advanced NSCLC.
Acta Oncol
; 59(9): 1051-1057, 2020 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-32543258
5.
Correction: Associations between detectable circulating tumor DNA and tumor glucose uptake measured by 18F-FDG PET/CT in early-stage non-small cell lung cancer.
BMC Cancer
; 23(1): 685, 2023 Jul 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-37474938
6.
Twice-daily chemoradiotherapy in limited-stage small-cell lung cancer - Authors' reply.
Lancet Oncol
; 22(6): e222, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-34087132
7.
Comorbidity and outcomes of concurrent chemo- and radiotherapy in limited disease small cell lung cancer.
Acta Oncol
; 55(11): 1349-1354, 2016 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-27549509
8.
Randomized phase II trial comparing twice daily hyperfractionated with once daily hypofractionated thoracic radiotherapy in limited disease small cell lung cancer.
Acta Oncol
; 55(5): 591-7, 2016 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-26494411
9.
Evaluation of Radiation Therapy Treatment Plans in a Randomized Phase 2 Trial Comparing 2 Schedules of Twice-Daily Thoracic Radiation Therapy in Limited Stage Small Cell Lung Cancer.
Int J Radiat Oncol Biol Phys
; 2024 Apr 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-38583494
10.
Treatment Outcomes of Older Participants in a Randomized Trial Comparing Two Schedules of Twice-Daily Thoracic Radiotherapy in Limited-Stage SCLC.
J Thorac Oncol
; 18(6): 803-812, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36716960
11.
Atezolizumab and stereotactic body radiotherapy in patients with advanced non-small cell lung cancer: safety, clinical activity and ctDNA responses-the ComIT-1 trial.
Mol Oncol
; 17(3): 487-498, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36330681
12.
Thoracic Radiotherapy in Limited-Stage SCLC-a Population-Based Study of Patterns of Care in Norway From 2000 Until 2018.
JTO Clin Res Rep
; 3(2): 100270, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-35146461
13.
Prognostic Value of Post First-Line Chemotherapy Glasgow Prognostic Score in Advanced Non-Small Cell Lung Cancer.
Clin Med Insights Oncol
; 16: 11795549221086578, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35342321
14.
Associations between Measured and Patient-Reported Physical Function and Survival in Advanced NSCLC.
Healthcare (Basel)
; 10(5)2022 May 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-35628059
15.
Patient-reported health-related quality of life from a randomized phase II trial comparing standard-dose with high-dose twice daily thoracic radiotherapy in limited stage small-cell lung cancer.
Lung Cancer
; 166: 49-57, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35183991
16.
Associations between tumor mutations in cfDNA and survival in non-small cell lung cancer.
Cancer Treat Res Commun
; 29: 100471, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34607221
17.
Prognostic value of absolute quantification of mutated KRAS in circulating tumour DNA in lung adenocarcinoma patients prior to therapy.
J Pathol Clin Res
; 7(3): 209-219, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33502820
18.
The Prognostic Effect of KRAS Mutations in Non-Small Cell Lung Carcinoma Revisited: A Norwegian Multicentre Study.
Cancers (Basel)
; 13(17)2021 Aug 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-34503114
19.
Associations between muscle measures, survival, and toxicity in patients with limited stage small cell lung cancer.
J Cachexia Sarcopenia Muscle
; 11(5): 1283-1290, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32725772
20.
Timing of Severe Toxicity from Chemotherapy in Patients With Lung Cancer.
Anticancer Res
; 40(11): 6399-6406, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-33109578